Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001421091 | SCV001623607 | likely benign | Primary ciliary dyskinesia | 2020-10-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000463546 | SCV001989965 | uncertain significance | not provided | 2019-05-20 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV001421091 | SCV002747959 | likely benign | Primary ciliary dyskinesia | 2022-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV000463546 | SCV001798840 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000463546 | SCV001975086 | uncertain significance | not provided | no assertion criteria provided | clinical testing |